Venlafaxine

From WikEM
Jump to: navigation, search

Administration

  • Type: SNRI
  • Dosage Forms:
  • Routes of Administration: Oral
  • Common Trade Names: Effexor

Adult Dosing

  • Extended release: 37.5-225mg PO daily
  • Immediate release: 75-375mg PO daily in 2-3 divided doses

Pediatric Dosing

Safety/efficacy not established

Special Populations

  • Pregnancy Rating: C
  • Lactation risk: Infant risk cannot be ruled out
  • Renal dosing: decrease dose by 25-50%
  • Hepatic dosing: decrease dose by 25-50%

Contraindications

  • Allergy to class/drug
  • MAOI use concomitantly or within past 14 days

Adverse Reactions

Serious

  • Seizure
  • Neuroleptic malignant syndrome, serotonin syndrome
  • GI bleed
  • Hepatitis
  • Hyponatremia
  • Exacerbation of depression, suicidality, mania

Common

  • Constipation, nausea, xerostomia, anorexia, weight loss
  • Dizziness, insomnia, somnolence, dream disorder, tremor, anxiety, blurred vision
  • Sweating
  • Hypertension
  • Sexual dysfunction

Pharmacology

  • Half-life: 5-11h
  • Metabolism: Hepatic, CYP2D6
  • Excretion: Mostly renal

Mechanism of Action

  • Inhibits serotonin, norepinephrine and dopamine reuptake

Comments

See Also

References

Authors

Claire